• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

There is strong evidence that sex chromosomes and sex hormones influence blood
pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities …

Nonadherence to antihypertensive medication is common, especially in those with apparent
treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of …

People with type 1 and type 2 diabetes are at risk of developing progressive chronic kidney
disease (CKD) and end-stage kidney failure. Hypertension is a major, reversible risk factor …

Hypertension remains the leading cause of cardiovascular disease and premature death
globally, affecting half of US adults. A high proportion of hypertensive patients exhibit …

Background The prevalence of medication nonadherence in the setting of resistant
hypertension (RH) varies from 5% to 80% in the published literature. The aim of this …

Although reports vary, the prevalence of true resistant hypertension and apparent treatment-
resistant hypertension (aTRH) has been reported to be 10.3% and 14.7%, respectively. As …

National and international hypertension guidelines recommend that adults with young-onset
hypertension (aged< 40 years at diagnosis) are reviewed by a hypertension specialist to …

Hypertension remains a significant risk factor for major cardiovascular events worldwide.
Poor adherence to treatment is extremely common in clinical practice, leading to …

Introduction Hypertension is the main global risk factor for cardiovascular disease. Despite
this, less than half of treated hypertensive patients are controlled. One reason for this is …